In Taiwan, medical devices are classified into four categories based on risk: Class I (low risk) requires minimal regulatory control; Class II (moderate risk) needs pre-market notification; Class III (high risk) requires a more rigorous approval process; and Class IV (highest risk) undergoes the most extensive evaluation before market authorization.